These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluconazole-resistant oral candidosis in HIV-infected patients. Diz Dios P; Ocampo Hermida A; Miralles Alvarez C; Iglesias Martin I; Otero Varela I AIDS; 1995 Jul; 9(7):809-10. PubMed ID: 7546428 [No Abstract] [Full Text] [Related]
4. [Therapy of candidiasis and cryptococcosis in AIDS]. Just-Nübling G Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745 [TBL] [Abstract][Full Text] [Related]
5. Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS. Tumbarello M; Bevilacqua N; Federico G; Morace G; Cauda R; Tacconelli E Clin Infect Dis; 1996 Jan; 22(1):179-80. PubMed ID: 8824996 [No Abstract] [Full Text] [Related]
6. [For oral candidiasis and co. Fluconazole remains in the forefront]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():90. PubMed ID: 15373066 [No Abstract] [Full Text] [Related]
7. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients]. Fortun Abete J Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305 [No Abstract] [Full Text] [Related]
8. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS]. Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371 [TBL] [Abstract][Full Text] [Related]
9. Role of fluconazole in the management of AIDS-related cryptococcosis, according to daily dosing. Manfredi R; Chiodo F Chemotherapy; 1998; 44(3):206-14. PubMed ID: 9612611 [TBL] [Abstract][Full Text] [Related]
10. The challenge of invasive fungal infection. de Pauw BE; Meunier F Chemotherapy; 1999 Jun; 45 Suppl 1():1-14. PubMed ID: 10394016 [TBL] [Abstract][Full Text] [Related]
11. Outpatient therapy of HIV-associated oral and oesophageal candidosis. Ustianowski AP; Leake H; Evans S Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351 [No Abstract] [Full Text] [Related]
12. Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study. Cartledge JD; Midgley J; Gazzard BG Genitourin Med; 1997 Dec; 73(6):471-4. PubMed ID: 9582463 [TBL] [Abstract][Full Text] [Related]
13. [Lymph node cryptococcosis in an AIDS patient on long-term fluconazole: relapse or cure?]. Ginsburg C; Aaron L; Lesueur A; Salmon-Ceron D; Sicard D Presse Med; 1997 Jun; 26(22):1049. PubMed ID: 9246116 [No Abstract] [Full Text] [Related]
14. Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei. Coppola S; Angarano G; Montagna MT; Congedo P; Monno L; Bellisario A; Pastore G Eur J Epidemiol; 1995 Apr; 11(2):243-4. PubMed ID: 7672085 [TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083 [TBL] [Abstract][Full Text] [Related]
16. Editorial response: A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Larsen RA Clin Infect Dis; 1999 Feb; 28(2):297-8. PubMed ID: 10064247 [No Abstract] [Full Text] [Related]